Enhanced efficacy antiperspirant compositions containing strontium or calcium
US6923952B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Aug 14, 2003 |
| Grant date | Aug 2, 2005 |
| Priority date | — |
| Expiry date | Aug 14, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61Q15/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are enhanced efficacy antiperspirant compositions containing a strontium salt and/or a calcium salt. In particular, there is disclosed an antiperspirant composition comprising a dermatologically acceptable carrier vehicle, about 8% to about 22% (USP) of an aluminum-zirconium chlorohydrate-gly antiperspirant salt, wherein the antiperspirant salt has an HPLC peak 5 area of at least 33%, and about 0.5% to about 15%, preferably about 1% to about 6%, by weight, of a water soluble salt selected from the group consisting of a water soluble strontium salt, a water soluble calcium salt and a mixture thereof. It has been found that the inclusion of a strontium salt and/or a calcium salt boosts the efficacy of a high peak 5 antiperspirant salt. As a preferred feature, the antiperspirant salt and the water soluble salt are dissolved in at least a portion of the carrier vehicle.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.